bf/NASDAQ:ILMN_icon.jpeg

NASDAQ:ILMN

Illumina Inc

  • Stock

USD

Last Close

138.68

28/03 20:00

Market Cap

22.33B

Beta: 1.18

Volume Today

912.92K

Avg: 1.23M

PE Ratio

−19.97

PFCF: 133.64

Issues Detected

Our system has detected quality issues with this report. The team is informed is working to resolve the issues. Please click the button below to request an expedited investigation.

  • industry

    Diagnostics & Research
  • exchange

    NASDAQ Global Select
  • website

    www.illumina.com
  • ipo date

    Jul 28, 2000
  • full time employees

    11,500
  • currency

    USD

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive he...Show More

Earnings

Earnings per Share (Estimate*)

0.511.522015-07-212017-08-012019-07-292021-08-052023-08-09

Revenue (Estimate*)

200M400M600M800M1B1.20B2015-07-212017-08-012019-07-292021-08-052023-08-09

*Estimate based on analyst consensus

founders

  • David R. Walt
  • John Stuelpnagel
  • Larry Bock
  • Satnam Alag

num employees

  • 5001-10000

recent investments

Money RaisedFunding RoundLead InvestorAnnounced DateOrganization Name
$9MSeries A - Mantra Bio04-01-2023Mantra Bio
Pre Seed Round - Mable (Neurolytic Healthcare)27-07-2022Mable (Neurolytic Healthcare)
$375MPost-IPO Equity - SomaLogic01-09-2021SomaLogic
£499.8KPre Seed Round - Concr01-04-2021Concr
$70MSeries F - Ginkgo Bioworks28-05-2020Ginkgo Bioworks
$390MSeries D - Grail06-05-2020Grail
$200MVenture Round - Helixis01-03-2018Helixis
$200MSeries B - Helix01-03-2018Helix
$2.8MSeed Round - Prospect Bio15-11-2016Prospect Bio
$2MSeed Round - VitageneNo17-02-2016Vitagene

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.